First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Working Capital to Net Assets Ratio

First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Working Capital to Net Assets ratio of 99.5% as of March 2026. Working capital of $256.29 Million (current assets of $289.40 Million minus current liabilities of $33.11 Million) is measured against net assets of $257.46 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can First Tracks Biotherapeutics, Inc. Ordin fund operations to measure how many days the company can operate on defensive assets alone.